Preclinical Evaluation of Novel Positron Emission Tomography (PET) Probes for Imaging Leucine-Rich Repeat Kinase 2 (LRRK2)

被引：2

作者：

Chen, Zhen ^{[1
,2
,3
]}

Chen, Jiahui ^{[2
,3
,4
]}

Mori, Wakana ^{[5
]}

Yi, Yongjia ^{[1
]}

Rong, Jian ^{[2
,3
,4
]}

Li, Yinlong ^{[2
,3
,4
]}

Leon, Erick R. Calderon ^{[6
]}

Shao, Tuo ^{[2
,3
]}

Song, Zhendong ^{[4
]}

Yamasaki, Tomoteru ^{[5
]}

Ishii, Hideki ^{[5
]}

Zhang, Yiding ^{[5
]}

Kokufuta, Tomomi ^{[5
]}

Hu, Kuan ^{[5
]}

Xie, Lin ^{[5
]}

Josephson, Lee ^{[2
,3
]}

Van, Richard ^{[6
]}

Shao, Yihan ^{[6
]}

Factor, Stewart ^{[7
]}

Zhang, Ming-Rong ^{[5
]}

Liang, Steven H. ^{[2
,3
,4
]}

机构：

[1] Nanjing Forestry Univ, Coll Chem Engn, Int Innovat Ctr Forest Chem & Mat, Jiangsu Key Lab Biomass Based Green Fuels & Chem,J, Nanjing 210037, Jiangsu, Peoples R China

[2] Harvard Med Sch, Massachusetts Gen Hosp, Div Nucl Med & Mol Imaging, Boston, MA 02114 USA

[3] Harvard Med Sch, Dept Radiol, Boston, MA 02114 USA

[4] Emory Univ, Dept Radiol & Imaging Sci, 1364 Clifton Rd, Atlanta, GA 30322 USA

[5] Natl Inst Radiol Sci, Natl Inst Quantum & Radiol Sci & Technol, Dept Radiopharmaceut Dev, Chiba 2638555, Japan

[6] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA

[7] Emory Univ, Dept Neurol, Jean & Paul Amos Parkinsons Dis & Movement Disorde, Sch Med, Atlanta, GA 30322 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2024年 / 67卷 / 04期

关键词：

PARKINSONS-DISEASE; DISCOVERY; MUTATIONS;

D O I：

10.1021/acs.jmedchem.3c01687

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Parkinson's disease (PD) is one of the most highly debilitating neurodegenerative disorders, which affects millions of people worldwide, and leucine-rich repeat kinase 2 (LRRK2) mutations have been involved in the pathogenesis of PD. Developing a potent LRRK2 positron emission tomography (PET) tracer would allow for in vivo visualization of LRRK2 distribution and expression in PD patients. In this work, we present the facile synthesis of two potent and selective LRRK2 radioligands [C-11]3 ([C-11]PF-06447475) and [F-18]4 ([F-18]PF-06455943). Both radioligands exhibited favorable brain uptake and specific bindings in rodent autoradiography and PET imaging studies. More importantly, [F-18]4 demonstrated significantly higher brain uptake in the transgenic LRRK2-G2019S mutant and lipopolysaccharide (LPS)-injected mouse models. This work may serve as a roadmap for the future design of potent LRRK2 PET tracers.

引用

页码：2559 / 2569

页数：11

共 50 条

[11] The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
Mark R. Cookson
Nature Reviews Neuroscience, 2010, 11 : 791 - 797
[12] Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration
Smith, WW
Pei, Z
Jiang, HB
Moore, DJ
Liang, YD
West, AB
Dawson, VL
Dawson, TM
Ross, CA
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (51) : 18676 - 18681
[13] The tale of proteolysis targeting chimeras (PROTACs) for Leucine-Rich Repeat Kinase 2 (LRRK2)
Konstantinidou, Markella
Oun, Asmaa
Pathak, Pragya
Zhang, Bidong
Wang, Zefeng
ter Brake, Frans
Dolga, Amalia M.
Kortholt, Arjan
Domling, Alexander
CHEMMEDCHEM, 2021, 16 (06) : 959 - 965
[14] Potent, selective and orally bioavailable leucine-rich repeat kinase 2 (LRRK2) inhibitors
Greshock, Thomas J.
Sanders, John M.
Drolet, Robert E.
Rajapakse, Hemaka A.
Chang, Ronald K.
Kim, Boyoung
Rada, Vanessa L.
Tiscia, Heather E.
Su, Hua
Lai, Ming-Tain
Sur, Sylvie M.
Sanchez, Rosa I.
Bilodeau, Mark T.
Renger, John J.
Kern, Jonathan T.
McCauley, John A.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (11) : 2631 - 2635
[15] Identification and Characterization of a Leucine-Rich Repeat Kinase 2 (LRRK2) Consensus Phosphorylation Motif
Pungaliya, Pooja P.
Bai, Yuchen
Lipinski, Kerri
Anand, Vasanti S.
Sen, Saurabh
Brown, Eugene L.
Bates, Brian
Reinhart, Peter H.
West, Andrew B.
Hirst, Warren D.
Braithwaite, Steven P.
PLOS ONE, 2010, 5 (10):
[16] Targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of Parkinson's disease
Domingos, Sofia
Duarte, Teresa
Saraiva, Lucilia
Guedes, Rita C.
Moreira, Rui
FUTURE MEDICINAL CHEMISTRY, 2019, 11 (15) : 1953 - 1977
[17] Differential Effects of Divalent Manganese and Magnesium on the Kinase Activity of Leucine-Rich Repeat Kinase 2 (LRRK2)
Lovitt, Brian
VanderPorten, Erica C.
Sheng, Zejuan
Zhu, Haitao
Drummond, Jake
Liu, Yichin
BIOCHEMISTRY, 2010, 49 (14) : 3092 - 3100
[18] Study on feasibility to develop a central nervous system (CNS) Leucine-rich repeat kinase 2 (LRRK2) PET tracer
Zeng, Z.
Miller, P.
Graham, T.
Tong, L.
Hesk, D.
Li, W.
Hostetler, E.
MOVEMENT DISORDERS, 2018, 33 : S691 - S691
[19] Function and dysfunction of leucine-rich repeat kinase 2 (LRRK2): Parkinson's disease and beyond
Bae, Jae Ryul
Lee, Byoung Dae
BMB REPORTS, 2015, 48 (05) : 243 - 248
[20] Leucine-rich repeat kinase 2 (LRRK2) mutations in a Swedish Parkinson cohort and a healthy nonagenarian
Belin, Andrea Carmine
Westerlund, Marie
Sydow, Olof
Lundstromer, Karin
Hakansson, Anna
Nissbrandt, Hans
Olson, Lars
Galter, Dagmar
MOVEMENT DISORDERS, 2006, 21 (10) : 1731 - 1734

← 1 2 3 4 5 →